Enhanced antitumour effect of photodynamic therapy by microtubule inhibitors.
暂无分享,去创建一个
J Moan | H E Danielsen | K. Berg | J. Moan | H. Danielsen | O. Kaalhus | L. Ma | K Berg | V Iani | L W Ma | V. Iani | O Kaalhus
[1] J Moan,et al. MITOTIC INHIBITION BY PHENYLPORPHINES AND TETRASULFONATED ALUMINIUM PHTHALOCYANINE IN COMBINATION WITH LIGHT , 1992, Photochemistry and photobiology.
[2] J. Denekamp,et al. Vinca alkaloids: anti-vascular effects in a murine tumour. , 1993, European journal of cancer.
[3] J Moan,et al. Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. , 1990, Cancer letters.
[4] M. Sevilla,et al. An ESR investigation of the reactions of glutathione, cysteine and penicillamine thiyl radicals: competitive formation of RSO., R., RSSR-., and RSS(.). , 1988, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[5] J Moan,et al. Photodynamic effects of Photofrin II on cell division in human NHIK 3025 cells. , 1988, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[6] J Moan,et al. Cellular inhibition of microtubule assembly by photoactivated sulphonated meso-tetraphenylporphines. , 1990, International journal of radiation biology.
[7] H. Kato,et al. Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer. , 1984, Chest.
[8] T. Dougherty,et al. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. , 1981, Cancer research.
[9] K. Berg,et al. The unpolymerized form of tubulin is the target for microtubule inhibition by photoactivated tetra(4-sulfonatophenyl)porphine. , 1992, Biochimica et biophysica acta.
[10] B. Monsarrat,et al. Taxol: pharmacology, metabolism and clinical implications. , 1993, Cancer surveys.
[11] D. Kessel,et al. TUMOR LOCALIZATION AND PHOTOSENSITIZATION BY SULFONATED DERIVATIVES OF TETRAPHENYLPORPHINE , 1987, Photochemistry and photobiology.
[12] J. Manfredi,et al. Taxol: an antimitotic agent with a new mechanism of action. , 1984, Pharmacology & therapeutics.
[13] E. Lloyd. The relative distributions of radioactive ytrium and strontium and the secondary deposition of 90Y built up from 90Sr. , 1961, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[14] M Jirsa,et al. Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude mice. , 1991, European journal of cancer.
[15] J. G. Armstrong,et al. Hodgkin's disease, carcinoma of the breast, and other tumors treated with vinblastine sulfate. , 1962, Cancer chemotherapy reports.
[16] W. Brade,et al. Critical Review of Pharmacology, Toxicology, Pharmacokinetics of Vincristine, Vindesine, Vinblastine , 1981 .
[17] J Moan,et al. A TEST OF DIFFERENT PHOTOSENSITIZERS FOR PHOTODYNAMIC TREATMENT OF CANCER IN A MURINE TUMOR MODEL , 1987, Photochemistry and photobiology.
[18] Kristian Berg,et al. Effect of sulfonation on the photosensitizing efficiency of aluminum phthalocyanine and meso-tetraphenylporphine in photodynamic therapy of cancer , 1994, Other Conferences.
[19] T J Dougherty,et al. Photoradiation in the treatment of recurrent breast carcinoma. , 1979, Journal of the National Cancer Institute.
[20] R. Donehower,et al. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. , 1988, Cancer research.
[21] J Moan,et al. Synergistic effects of photoactivated tetra(4-sulfonatophenyl)porphine and nocodazole on microtubule assembly, accumulation of cells in mitosis and cell survival. , 1992, Journal of photochemistry and photobiology. B, Biology.
[22] J Moan,et al. Lysosomes as photochemical targets , 1994, International journal of cancer.